Visit Funding: How Much Did They Raise & Key Investors

How Much Did Visit Raise?
Funding & Key Investors

Visit, a New Delhi-based innovator in the digital health sector, has successfully secured a major strategic investment, bringing its total capital accumulation to $31.1M. This latest infusion of $29.7M marks a pivotal shift in the company's trajectory, moving from its foundational roots toward a more robust enterprise-level operational model. By leveraging advanced artificial intelligence to bridge the gap between symptom diagnosis and specialist consultation, the firm is positioning itself as a critical infrastructure player in the rapidly evolving Indian health-tech landscape.

The recent financing round underscores a growing market confidence in AI-driven health management platforms. As the company scales its operations, this capital injection provides the necessary runway to enhance its proprietary diagnostic algorithms and expand its service ecosystem, which currently encompasses chronic condition management and lifestyle optimization tools.

What is Visit?

Visit

Software

Healthcare Software

Mobile App Development

Visit operates as a sophisticated AI-driven platform designed to streamline the patient journey. By integrating symptom assessment, lifestyle tracking, and direct access to medical specialists, the company addresses the fragmentation often found in traditional healthcare delivery. Its market position is defined by its ability to offer a seamless, end-to-end digital experience that caters to both individual wellness needs and the complex requirements of chronic disease management. The platform serves as a digital gateway, utilizing data-driven insights to improve clinical outcomes and operational efficiency for healthcare providers and patients alike.

How much funding has Visit raised?

Visit has raised a total of $31.1M across 2 funding rounds:

2021

Angel/Seed

$1.4M

2024

Stock Offering

$29.7M

Angel/Seed (2021): $1.4M with participation from Kunal Bahl, MapmyIndia, Murali Krishna, and Rohit Bansal

Stock Issuance/Offering (2024): $29.7M led by Docprime

Key Investors in Visit

Docprime

Docprime is a comprehensive healthcare platform that simplifies healthcare and insurance benefits by offering services such as online consultations, claims management, and wellness tracking.

MapmyIndia

C.E. Info Systems Limited, known as MapmyIndia, is a leader in advanced digital maps, geospatial software, and location-based IoT technologies.

Kunal Bahl

A prominent angel investor and entrepreneur known for supporting high-growth technology ventures in the Indian startup ecosystem.

What's next for Visit?

With the successful closure of this major strategic investment, Visit is poised to accelerate its product development roadmap and deepen its market penetration. The strategic focus will likely shift toward scaling its B2B2C offerings and enhancing the interoperability of its platform with existing healthcare infrastructure. By prioritizing the integration of advanced geospatial and diagnostic data, the company aims to solidify its role as a primary digital health partner. Future growth will be contingent on the firm's ability to maintain high standards of clinical accuracy while navigating the regulatory complexities inherent in the digital health sector, ultimately aiming to redefine the standard of care through scalable, technology-first solutions.

See full Visit company page

See More Financial Insights